GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzamend Neuro Inc (FRA:9ZT1) » Definitions » 12-1 Month Momentum %

Alzamend Neuro (FRA:9ZT1) 12-1 Month Momentum % : -74.44% (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alzamend Neuro 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-05), Alzamend Neuro's 12-1 Month Momentum % is -74.44%.

The industry rank for Alzamend Neuro's 12-1 Month Momentum % or its related term are showing as below:

FRA:9ZT1's 12-1 Month Momentum % is ranked worse than
96.69% of 1480 companies
in the Biotechnology industry
Industry Median: -24.245 vs FRA:9ZT1: -74.44

Competitive Comparison of Alzamend Neuro's 12-1 Month Momentum %

For the Biotechnology subindustry, Alzamend Neuro's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzamend Neuro's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzamend Neuro's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alzamend Neuro's 12-1 Month Momentum % falls into.



Alzamend Neuro  (FRA:9ZT1) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzamend Neuro  (FRA:9ZT1) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Alzamend Neuro 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Alzamend Neuro's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzamend Neuro (FRA:9ZT1) Business Description

Traded in Other Exchanges
Address
3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA, USA, 30326
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Alzamend Neuro (FRA:9ZT1) Headlines

No Headlines